May 10th 2024
The blend of long-chain polyunsaturated fatty acids and long-chain monounsaturated fatty acids combines the heart and brain health benefits of omegas-3s with the skin and metabolic health benefits of omegas 9 and 11.
GC Rieber VivoMega to make significant investment in facility expansion
May 6th 2022GC Rieber VivoMega has announced a five-year $75 million investment plan to build a new facility at its manufacturing campus. The new facility will enable the company to more than double the output of its high-end triglyceride form of omega-3s EPA and DHA.
Vitamin D and omega-3 supplementation may help reduce risk of autoimmune disease, says recent study
February 1st 2022The vitamin D and omega-3 trial (VITAL) is a nationwide, randomized, double-blind, placebo-controlled trial with a two-by-two factorial design. The study consisted of 25,871 participants, 12,786 of which were men aged 50 or over, and 13,085 of which were women aged 55 or over.
Retailing dietary supplements and natural products in 2022: An opportunity for improvement
February 1st 2022COVID will continue to impact supplement retailing. But instead of scrambling to adjust, brands have the opportunity to hone their omnichannel strategy and improve long-distance retail relationships.
GOED publishes report on omega-3 supplement consumers
November 23rd 2021The Global Organization for EPA and DHA Omega-3s, in partnership with Trust Transparency Center, published a report, Consumer Perceptions on Omega-3 Supplements, with market research on supplement consumers in the United States.
GC Rieber VivoMega launches omega-3 softgel sampling program ahead of SupplySide West 2021
October 6th 2021Targeting North American customers, the VivoMega softgel sampling program will ship a full month’s worth of softgels along with a label and look “that portrays the quality that VivoMega promises.”